New drugs help treat cancer and HIV
Print Edition
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a US$500,000 medical prize.
The recipients of the annual Albany Medical Center Prize in Medicine and Biomedical Research, announced yesterday, are being recognized for their studies of the immune system that have led to innovative treatments for cancer, HIV and other diseases.
They are James Allison of the University of Texas MD Anderson Cancer Center; Dr Carl June of the Perelman School of Medicine, University of Pennsylvania; and Dr Steven Rosenberg of the National Cancer Institute. They’ll receive the award on September 26 in Albany, New York.
“Their research has given hope to many who otherwise faced a certain death sentence, and has inspired the work of hundreds of other researchers to investigate new pathways for treatment,” said Dr Vincent Verdile, dean of Albany Medical College. “Their impact on the development of cancer immunotherapy — and where it goes from here — is unsurpassed.”
Immunotherapy harnesses the power of the immune system to attack cancer cells and tumors. In the 1980s, Rosenberg theorized that stimulating white blood cells called T cells could provoke immune reactions. His work led to the first immunotherapy drug approved by the US FDA in 1992.
The drug is among a new class of genetically engineered antibody-based medicines that are transforming treatment for several kinds of cancer.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
